Exact Mass: 486.2901
Exact Mass Matches: 486.2901
Found 500 metabolites which its exact mass value is equals to given mass value 486.2901
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hydrocortisone cypionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(2S)-2-[[(2S)-2-[[(2S)-2-Amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
PA(O-20:4(5Z,8Z,11Z,14Z)/2:0)
PA(O-20:4(5Z,8Z,11Z,14Z)/2:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(O-20:4(5Z,8Z,11Z,14Z)/2:0), in particular, consists of one 5Z,8Z,11Z,14Z-eicosatetraenoyl chain to the C-1 atom, and one acetyl to the C-2 atom. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphate
1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(22:4(7Z,10Z,13Z,16Z)/0:0)
LysoPA(22:4(7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:4(7Z,10Z,13Z,16Z)/0:0), in particular, consists of one chain of adrenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(2S)-2-[[(2S)-2-[[(2S)-2-Amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
DG(2:0/6 keto-PGF1alpha/0:0)
DG(2:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/2:0/0:0)
DG(6 keto-PGF1alpha/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/6 keto-PGF1alpha)
DG(2:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(6 keto-PGF1alpha/0:0/2:0)
DG(6 keto-PGF1alpha/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/TXB2/0:0)
DG(2:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(TXB2/2:0/0:0)
DG(TXB2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/TXB2)
DG(2:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(TXB2/0:0/2:0)
DG(TXB2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Zhankuic acid C
A steroid acid that is ergosta-8,24(28)-dien-26-oic acid substituted by hydroxy groups at positions 3 and 12, a methyl group at position 4 and oxo groups at positions 7 and 11 (the 3alpha,4alpha,5alpha,12alpha stereoisomer). Isolated from Antrodia cinnamomea and Antrodia camphorata, it exhibits antineoplastic activity.
10,11-Dihydro-12-hydroxynerolidol 3-O-beta-D-2-acetylglucoside
{(E)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl oleate
12-deacetoxy-23-acetoxy-19-O-acetylscalarin|12-deacetoxy-23-acetoxyscalarin
(3beta,16alpha,23?鈥?24?鈥?-form-3,16,24,28-Tetrahydroxystigmasta-7,9(11)-dien-21,23-olide|Vernoniol A4
2-((2E,6E,13E)-5-acetoxy-15-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,13-trienyl)-6-methylhydroquinol|2-<(2E,6E,13E)-5-acetoxy-15-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,13-trienyl>-6-methylhydroquinol
(2S)-1-O-((7Z,10Z,13Z)-hexadecatrienoyl)-3-O-beta-D-galactopyranosylglycerol|(2S)-1-O-(7Z,10Z,13Z-hexadecatrienoyl)-3-O-beta-galactopyranosylglycerol
ethyl 7beta-hydroxy-4,4,14alpha-trimethyl-3,11,15-trioxo-5alpha-chol-8-en-24-oate|ethyl lucidenate A
(5S,9S,10S,13R,17R,20S,21S,22R,23S,24R,28R)-21,23;22,28-diepoxy-21,24-dihydroxy-stigmasta-8,14-en-3,15-dione|vernoanthelsterone A
5-alpha-methoxy-4,5-dihydrojaborosalactone B|5alpha-methoxy-4,5-dihydro-jaborosalactone B
11alpha,12alpha-epoxy-2alpha,3beta,6beta-trihydroxy-24-norurs-4(23)-en-28m13beta-olide|chinenol A
(1R,5aS,5bR,7aR,8R,11aR,11bS,13S,13aS,13bR)-1-(acetyloxy)-8-[(acetyloxy)methyl]-5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a,13b-hexadecahydro-5b,8,11a,13a-tetramethylchryseno[1,2-c]furan-3(1H)-one|hyrtiosin C
3alpha-(5-methyldodeca-2E,4E,6E-trienoyloxy)-8,9alpha-dihydroxy-8-methoxy-10alphaH-eremophilon-8,12-olide|3alpha-<5-methyldodeca-2E,4E,6E-trienoyloxy>-8,9alpha-dihydroxy-8-methoxy-10alphaH-eremophilon-8,12-olide
Ala Ile Gln Arg
Ala Ile Arg Gln
Ala Leu Gln Arg
Ala Leu Arg Gln
Ala Gln Ile Arg
Ala Gln Leu Arg
Ala Gln Arg Ile
Ala Gln Arg Leu
Ala Arg Ile Gln
Ala Arg Leu Gln
Ala Arg Gln Ile
Ala Arg Gln Leu
Asp Lys Lys Pro
Asp Lys Pro Lys
Asp Pro Lys Lys
Glu Ile Ile Ile
Glu Ile Ile Leu
Glu Ile Leu Ile
Glu Ile Leu Leu
Glu Leu Ile Ile
Glu Leu Ile Leu
Glu Leu Leu Ile
Glu Leu Leu Leu
Gly Arg Arg Val
Gly Arg Val Arg
Gly Val Arg Arg
Ile Ala Gln Arg
Ile Ala Arg Gln
Ile Glu Ile Ile
Ile Glu Ile Leu
Ile Glu Leu Ile
Ile Glu Leu Leu
Ile Ile Glu Ile
Ile Ile Glu Leu
Ile Ile Ile Glu
Ile Ile Lys Asn
Ile Ile Leu Glu
Ile Ile Asn Lys
Ile Ile Asn Gln
Ile Ile Gln Asn
Ile Lys Ile Asn
Ile Lys Leu Asn
Ile Lys Asn Ile
Ile Lys Asn Leu
Ile Lys Gln Val
Ile Lys Val Gln
Ile Leu Glu Ile
Ile Leu Glu Leu
Ile Leu Ile Glu
Ile Leu Lys Asn
Ile Leu Leu Glu
Ile Leu Asn Lys
Ile Leu Asn Gln
Ile Leu Gln Asn
Ile Asn Ile Lys
Ile Asn Ile Gln
Ile Asn Lys Ile
Ile Asn Lys Leu
Ile Asn Leu Lys
Ile Asn Leu Gln
Ile Asn Gln Ile
Ile Asn Gln Leu
Ile Gln Ala Arg
Ile Gln Ile Asn
Ile Gln Lys Val
Ile Gln Leu Asn
Ile Gln Asn Ile
Ile Gln Asn Leu
Ile Gln Gln Val
Ile Gln Arg Ala
Ile Gln Val Lys
Ile Gln Val Gln
Ile Arg Ala Gln
Ile Arg Gln Ala
Ile Val Lys Gln
Ile Val Gln Lys
Ile Val Gln Gln
Lys Asp Lys Pro
Lys Asp Pro Lys
Lys Ile Ile Asn
Lys Ile Leu Asn
Lys Ile Asn Ile
Lys Ile Asn Leu
Lys Ile Gln Val
Lys Ile Val Gln
Lys Lys Asp Pro
Lys Lys Pro Asp
Lys Leu Ile Asn
Lys Leu Leu Asn
Lys Leu Asn Ile
Lys Leu Asn Leu
Lys Leu Gln Val
Lys Leu Val Gln
Lys Asn Ile Ile
Lys Asn Ile Leu
Lys Asn Leu Ile
Lys Asn Leu Leu
Lys Pro Asp Lys
Lys Pro Lys Asp
Lys Pro Arg Ser
Lys Pro Ser Arg
Lys Gln Ile Val
Lys Gln Leu Val
Lys Gln Val Ile
Lys Gln Val Leu
Lys Arg Pro Ser
Lys Arg Ser Pro
Lys Ser Pro Arg
Lys Ser Arg Pro
Lys Val Ile Gln
Lys Val Leu Gln
Lys Val Gln Ile
Lys Val Gln Leu
Leu Ala Gln Arg
Leu Ala Arg Gln
Leu Glu Ile Ile
Leu Glu Ile Leu
Leu Glu Leu Ile
Leu Glu Leu Leu
Leu Ile Glu Ile
Leu Ile Glu Leu
Leu Ile Ile Glu
Leu Ile Lys Asn
Leu Ile Leu Glu
Leu Ile Asn Lys
Leu Ile Asn Gln
Leu Ile Gln Asn
Leu Lys Ile Asn
Leu Lys Leu Asn
Leu Lys Asn Ile
Leu Lys Asn Leu
Leu Lys Gln Val
Leu Lys Val Gln
Leu Leu Glu Ile
Leu Leu Glu Leu
Leu Leu Ile Glu
Leu Leu Lys Asn
Leu Leu Leu Glu
Leu Leu Asn Lys
Leu Leu Asn Gln
Leu Leu Gln Asn
Leu Asn Ile Lys
Leu Asn Ile Gln
Leu Asn Lys Ile
Leu Asn Lys Leu
Leu Asn Leu Lys
Leu Asn Leu Gln
Leu Asn Gln Ile
Leu Asn Gln Leu
Leu Gln Ala Arg
Leu Gln Ile Asn
Leu Gln Lys Val
Leu Gln Leu Asn
Leu Gln Asn Ile
Leu Gln Asn Leu
Leu Gln Gln Val
Leu Gln Arg Ala
Leu Gln Val Lys
Leu Gln Val Gln
Leu Arg Ala Gln
Leu Arg Gln Ala
Leu Val Lys Gln
Leu Val Gln Lys
Leu Val Gln Gln
Asn Ile Ile Lys
Asn Ile Ile Gln
Asn Ile Lys Ile
Asn Ile Lys Leu
Asn Ile Leu Lys
Asn Ile Leu Gln
Asn Ile Gln Ile
Asn Ile Gln Leu
Asn Lys Ile Ile
Asn Lys Ile Leu
Asn Lys Leu Ile
Asn Lys Leu Leu
Asn Leu Ile Lys
Asn Leu Ile Gln
Asn Leu Lys Ile
Asn Leu Lys Leu
Asn Leu Leu Lys
Asn Leu Leu Gln
Asn Leu Gln Ile
Asn Leu Gln Leu
Asn Gln Ile Ile
Asn Gln Ile Leu
Asn Gln Leu Ile
Asn Gln Leu Leu
Asn Arg Val Val
Asn Val Arg Val
Asn Val Val Arg
Pro Asp Lys Lys
Pro Lys Asp Lys
Pro Lys Lys Asp
Pro Lys Arg Ser
Pro Lys Ser Arg
Pro Arg Lys Ser
Pro Arg Ser Lys
Pro Ser Lys Arg
Pro Ser Arg Lys
Gln Ala Ile Arg
Gln Ala Leu Arg
Gln Ala Arg Ile
Gln Ala Arg Leu
Gln Ile Ala Arg
Gln Ile Ile Asn
Gln Ile Lys Val
Gln Ile Leu Asn
Gln Ile Asn Ile
Gln Ile Asn Leu
Gln Ile Gln Val
Gln Ile Arg Ala
Gln Ile Val Lys
Gln Ile Val Gln
Gln Lys Ile Val
Gln Lys Leu Val
Gln Lys Val Ile
Gln Lys Val Leu
Gln Leu Ala Arg
Gln Leu Ile Asn
Gln Leu Lys Val
Gln Leu Leu Asn
Gln Leu Asn Ile
Gln Leu Asn Leu
Gln Leu Gln Val
Gln Leu Arg Ala
Gln Leu Val Lys
Gln Leu Val Gln
Gln Asn Ile Ile
Gln Asn Ile Leu
Gln Asn Leu Ile
Gln Asn Leu Leu
Gln Gln Ile Val
Gln Gln Leu Val
Gln Gln Val Ile
Gln Gln Val Leu
Gln Arg Ala Ile
Gln Arg Ala Leu
Gln Arg Ile Ala
Gln Arg Leu Ala
Gln Val Ile Lys
Gln Val Ile Gln
Gln Val Lys Ile
Gln Val Lys Leu
Gln Val Leu Lys
Gln Val Leu Gln
Gln Val Gln Ile
Gln Val Gln Leu
Arg Ala Ile Gln
Arg Ala Leu Gln
Arg Ala Gln Ile
Arg Ala Gln Leu
Arg Gly Arg Val
Arg Gly Val Arg
Arg Ile Ala Gln
Arg Ile Gln Ala
Arg Lys Pro Ser
Arg Lys Ser Pro
Arg Leu Ala Gln
Arg Leu Gln Ala
Arg Asn Val Val
Arg Pro Lys Ser
Arg Pro Ser Lys
Arg Gln Ala Ile
Arg Gln Ala Leu
Arg Gln Ile Ala
Arg Gln Leu Ala
Arg Arg Gly Val
Arg Arg Val Gly
Arg Ser Lys Pro
Arg Ser Pro Lys
Arg Val Gly Arg
Arg Val Asn Val
Arg Val Arg Gly
Arg Val Val Asn
Ser Lys Pro Arg
Ser Lys Arg Pro
Ser Pro Lys Arg
Ser Pro Arg Lys
Ser Arg Lys Pro
Ser Arg Pro Lys
Val Gly Arg Arg
Val Ile Lys Gln
Val Ile Gln Lys
Val Ile Gln Gln
Val Lys Ile Gln
Val Lys Leu Gln
Val Leu Gln Gln
Val Asn Arg Val
Val Asn Val Arg
Val Gln Ile Gln
Val Gln Leu Gln
Val Gln Gln Ile
Val Gln Gln Leu
Val Arg Gly Arg
Val Arg Asn Val
Val Arg Arg Gly
Val Arg Val Asn
Val Val Asn Arg
Val Val Arg Asn
arachidonoyl-(2-(4-bezenesulfonamide)ethyl)amide
ST 29:5;O6
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
{2-[2-({3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-4,3,5-trien-7-yl]methyl}(methyl)-amino]propyl}amino)ethyl]-4,5-dimethoxyphenyl}acetic acid
Kendomycin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins
PA(O-20:4(5Z,8Z,11Z,14Z)/2:0)
PA(O-20:4(5Z,8Z,11Z,14Z)/2:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(O-20:4(5Z,8Z,11Z,14Z)/2:0), in particular, consists of one 5Z,8Z,11Z,14Z-eicosatetraenoyl chain to the C-1 atom, and one acetyl to the C-2 atom. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. 2-Acetyl-1-(5Z,8Z,11Z,14Z-eicosatetraenyl)-sn-glycero-phosphate is an ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. [HMDB]
(2S)-2-[[(2S)-2-[[(2S)-2-Amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
Novamethymycin(1+)
An organic cation that is the conjugate acid of novamethymycin, obtained by protonation of the tertiary amino group; major species at pH 7.3.
[(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-bis(azaniumyl)-3-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxy-5-methyloxan-4-yl]-methylazanium
(2S)-2-[[(2S)-2-[[(2S,3S,7R)-2,3-diamino-8-(2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl)-7-hydroxyoctanoyl]amino]propanoyl]amino]-3-methylbutanoic acid
Tubelactomicin A
A 16-membered macrolide which exhibits strong and specific antimicrobial activities against rapid-growing Mycobacteria including drug-resistant strains. It is isolated from the culture broth of Nocardia sp.MK703-102F1
2-(7Z,10Z,13Z)-hexadecatrienoyl-3-(beta-D-galactosyl)-sn-glycerol
1-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(4-fluorophenyl)-1-methylurea
1-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
1-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propylurea
[1-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,10E,13E)-hexadeca-7,10,13-trienoate
(2-hydroxy-3-phosphonooxypropyl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate
1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphate
N-(2-(4-benzenesulfonamide)-ethyl) arachidonoyl amine
LPEt(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMeLPA(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved